I have sufficient content from the textbooks to provide a thorough, well-cited answer. Here it is:
Alcohol Withdrawal Seizures
Pathophysiology
Chronic alcohol consumption causes upregulation of NMDA glutamate receptors and downregulation of GABA-A receptors as the CNS compensates for alcohol's inhibitory effects. When alcohol is abruptly stopped, the resulting imbalance produces CNS hyperexcitability - the substrate for withdrawal seizures. This is the same mechanism underlying the broader alcohol withdrawal syndrome (AWS).
Timing and Clinical Features
| Phase | Timing | Event |
|---|
| Early withdrawal | 6-24 h | Tremor, anxiety, insomnia, nausea, tachycardia |
| Hallucinosis | 12-48 h | Tactile > visual > auditory hallucinations |
| Seizures | 6-48 h (peak 24-48 h) | Generalized tonic-clonic |
| Delirium tremens | 60+ h (peaks day 5) | Agitation, fever, autonomic instability |
Key seizure characteristics:
- Seizures occur 6 to 48 hours after reduction or cessation of alcohol; 90% occur within 48 hours
- Typically generalized tonic-clonic (rarely partial - focal seizures should prompt imaging)
- 90% of patients who seize have 1-6 seizures; 60% have multiple seizures within a 6-hour period
- Short or absent postictal period is common
- Status epilepticus is rare in pure alcohol withdrawal
- ~1/3 of patients with withdrawal seizures go on to develop delirium tremens
- Alcohol withdrawal seizures account for approximately one-third of all hospital admissions for seizures
(Rosen's Emergency Medicine; Tintinalli's Emergency Medicine; Bradley & Daroff's Neurology in Clinical Practice)
Risk Factors for Seizures
- Prior history of alcohol withdrawal seizure - the single strongest predictor
- Prior delirium tremens
- High and prolonged alcohol intake
- Multiple prior detoxifications (kindling effect)
- Comorbid seizure disorders, structural brain lesions
- Older age
- Concurrent use of other substances
Differential Diagnosis
Before attributing a seizure to alcohol withdrawal, exclude:
- Traumatic brain injury / intracranial hemorrhage (especially subdural - common in alcoholics from falls)
- Hypoglycemia (always check point-of-care glucose)
- Hyponatremia, hypomagnesemia
- CNS infection (meningitis, encephalitis)
- Non-compliance with antiepileptic medications
- Idiopathic epilepsy
- Withdrawal from other sedatives (benzodiazepines, barbiturates, baclofen)
- Toxic ingestion (isoniazid, tricyclics, stimulants, organophosphates)
- Wernicke's encephalopathy
Focal seizures or focal deficits in the postictal period mandate urgent CT head.
Workup
- Point-of-care glucose - mandatory first step
- Basic metabolic panel: sodium, magnesium, phosphate, calcium
- Liver function tests, CBC
- Toxicology screen
- CT head: indicated for new-onset seizures, focal features, trauma history, or failure to return to baseline
- LP if meningitis/encephalitis is suspected
- CIWA-Ar scale to assess withdrawal severity
Treatment
First-line: Benzodiazepines - the mainstay of therapy. They act at GABA-A receptors, directly counteracting the neurochemical defect, and are effective for both active seizure termination and prevention of further seizures.
| Agent | Dose (IV) | Notes |
|---|
| Diazepam | 10-20 mg IV over 2 min; repeat q5-10 min | Long-acting; active metabolites provide self-tapering effect |
| Lorazepam | 2-4 mg IV; repeat q15-20 min | Preferred in liver disease; no active metabolites |
| Oxazepam | 15-30 mg PO | Good for mild withdrawal; preferred in liver disease |
No single benzodiazepine is superior to the others for alcohol withdrawal seizures. IV is preferred when the patient is actively seizing or vomiting. IM lorazepam and midazolam have reliable absorption; IM diazepam is erratic.
Uncomplicated withdrawal (no seizures, no DT): Oral benzodiazepines with symptom-triggered dosing guided by CIWA-Ar scoring.
Refractory cases (failure to respond to ~50-100 mg diazepam equivalent in the first hour):
- Phenobarbital 65 mg IV q15-30 min up to 260 mg - acts on a different site of the GABA-A receptor; often requires intubation due to respiratory depression
- Propofol 5 mcg/kg/min titrated to effect - virtually always requires intubation; risk of propofol infusion syndrome with prolonged use (>48 h at >5 mg/kg/h)
- Dexmedetomidine - useful adjunct for autonomic symptoms
(Tintinalli's, Table 185-2; Bradley & Daroff's Neurology)
What NOT to use:
- Phenytoin is ineffective for alcohol withdrawal seizures and may in fact lower the seizure threshold. It is not indicated.
Supportive Care
- Thiamine 100 mg IV/IM before any glucose administration (prevent precipitating Wernicke's)
- Folate 1 mg daily
- IV fluids for dehydration
- Correct electrolytes: hypokalemia, hypomagnesemia, hypophosphatemia are common
- Quiet, low-stimulation environment
- Close monitoring of vital signs and respiratory status
Special Considerations
Prior history of withdrawal seizures: Start benzodiazepines early - most seizures occur within the first 24 hours. Initial dose: lorazepam 2 mg IV or diazepam 5 mg IV, frequently repeated.
Partial/focal seizures: Up to 50% of alcohol-related seizures are partial, and ~20% of those have underlying structural lesions (hematoma, tumor, vascular malformation). Emergent CT is indicated for new-onset partial seizures.
New-onset seizures: Require full workup. If imaging, labs, and exam are normal and the patient remains seizure-free with no withdrawal signs after 4-6 hours of observation, discharge is appropriate with outpatient follow-up. Long-term antiepileptic therapy is not indicated for pure alcohol withdrawal seizures.
Disposition
| Indication | Disposition |
|---|
| Mild withdrawal, responds to ED treatment, no major comorbidities | Detox unit or discharge home with reliable caregiver + outpatient referral |
| Alcohol withdrawal seizure | Admit |
| Prior DT, advanced age, withdrawal not responding to treatment | Admit |
| Refractory withdrawal requiring phenobarbital/propofol | ICU |
Follow-up within 24-48 hours is recommended for discharged patients.
Sources:
- Rosen's Emergency Medicine: Concepts and Clinical Practice (10th ed.)
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide (9th ed.), Ch. 185
- Bradley and Daroff's Neurology in Clinical Practice (8th ed.)
- Frameworks for Internal Medicine